Caplin Point Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : CAPLIPOINT
NIFTY : Nifty 500

About Company

Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams and other external applications. It is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Market Cap. ₹14,021 Cr.

52 Week - High/Low ₹2,641/1,225

P/E Ratio 43.40

P/B Ratio 10.09

Enterprise Value ₹13,818 Cr.

ROE % 22.69

RSI Value 40.09

EMA 50 2006.2

EMA 200 1919.88

Net Profit 284 Cr.

Net Profit 3year growth 81.6 Cr.

Net Profit 3 year (back) 156 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 20.36 %

Current Ratio 5.89 %

100 Day SMA 2,141 Rs.

200 Day SMA 1,950 Rs.

21 Day SMA 1,950 Rs.

50 Day SMA 1,981 Rs.

Book Value 183 Rs.

EV/EBITDA Ratio 31

QoQ EPS Growth -29 %

QoQ Operating Profit Growth -21 %

QoQ Sales Growth -11 %

Sales Latest Quarter 185 Cr.

YoY Sales Growth 39 %

Market Cap. ₹14,021 Cr.

52 Week - High/Low ₹2,641/1,225

P/E Ratio 27.19

P/B Ratio 6.05

Enterprise Value ₹13,476 Cr.

ROE % 22.97

RSI Value 40.09

EMA 50 2006.2

EMA 200 1919.88

Net Profit 457 Cr.

Net Profit 3year growth 4.19 Cr.

Net Profit 3 year (back) 242 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 17.68 %

Current Ratio 5.71 %

100 Day SMA 2,141 Rs.

200 Day SMA 1,950 Rs.

21 Day SMA 1,950 Rs.

50 Day SMA 1,981 Rs.

Book Value 305 Rs.

EV/EBITDA Ratio 19

QoQ EPS Growth 6 %

QoQ Operating Profit Growth -1 %

QoQ Sales Growth 2 %

Sales Latest Quarter 493 Cr.

YoY Sales Growth 13 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages